News: Indonesia

In the healthcare industry, public trust is not built overnight. It grows through consistent quality assurance, adherence to standards, and contributions that are tangibly felt by society. As demands for transparency continue to rise, healthcare companies are expected not only to deliver good products, but also to establish accurate and…

Dexa Medica has once again affirmed its role as a pioneer in Indonesia’s pharmaceutical industry through an award presented by the National Agency of Drug and Food Control (BPOM) of the Republic of Indonesia. The BPOM Achievement Award 2026 in the category of Pioneer with the Highest Number of Phytopharmaceutical…

Winning the award for eight consecutive times, Dexa Group demonstrates long-term consistency in building public trust. This commitment has once again led Dexa Group to receive the Indonesia Public Relations Awards (IPRA) 2026 with the title of Best Public Relations 2026 in Public Trust Building through Ethical Pharmaceutical Practices. This…

Amid ongoing public discussions regarding the use of prescription medicines, it is important for the public to understand the meaning of the symbol displayed on medicine packaging. The red circle symbol with the letter “K” does not indicate that the medicine is dangerous; rather, it signifies that the product is…

Dexa Group has once again achieved a strategic milestone by receiving the Indonesia CEO Excellence Award 2025, organized by WartaEkonomi.co.id Research and Consulting. This award recognizes visionary leadership that consistently drives business sustainability while strengthening the pharmaceutical sector’s contribution to national health resilience. The award was presented by Muhamad Ihsan,…

JAKARTA – On the occasion of the 61st National Health Day (HKN), Dexa Medica achieved a significant milestone by receiving the Karya Anak Bangsa Award from the Ministry of Health of the Republic of Indonesia, recognizing it as the pharmaceutical industry with the highest number of clinical trials for natural-based…

As global interest in herbal medicines continues to grow, only a limited number of products are developed with rigorous scientific methods and supported by strong clinical evidence. DLBS addresses this gap through the development of Integrative Modern Natural Medicines—therapeutics based on defined bioactive fractions with clear mechanisms of action and…

Sebagai bagian dari komitmen Dexa Medica untuk terus meningkatkan kualitas dan kepercayaan konsumen, kami selalu melakukan inovasi pada setiap produk kami — termasuk Folamil Genio, suplemen multivitamin dan mineral yang diformulasikan khusus untuk memenuhi kebutuhan nutrisi ibu hamil. Dalam memberikan pengalaman yang lebih baik bagi para moms, kini Folamil Genio…

Minister of Health Budi Gunadi Sadikin has set a target for 60–70 million Indonesians to receive free health screenings by 2025. In support of this initiative, PT Dexa Medica continues to contribute through its Cek Segitiga Gratis program, which recently took place at the Car Free Day area on Boulevard…

Cikarang, October 16th, 2025 - A delegation from the World Health Organization (WHO) and Indonesia’s National Agency for Drug and Food Control (BPOM RI) visited Dexa Laboratories of Biomolecular Sciences (DLBS) to observe firsthand how Indonesia’s biodiversity is being utilized in pharmaceutical research for the development of Modern Indonesian Natural…